Retraction: Molecular Mechanisms of Nanosized Titanium Dioxide–Induced Pulmonary Injury in Mice (PLoS ONE (2013) 8: 2 (e55563) DOI: 10.1371/journal.pone.0055563);Molecular Mechanisms of Nanosized Titanium Dioxide-Induced Pulmonary Injury in Mice

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Li, Bing ^a   Ze, Yuguan ^a   Sun, Qingqing ^a   Zhang, Ting ^b,c   Sang, Xuezi ^a   Cui, Yaling ^a   Wang, Xiaochun ^a   Gui, Suxin ^a   Tan, Danlin ^a   Zhu, Min ^a   Zhao, Xiaoyang ^a   Sheng, Lei ^a   Wang, Ling ^a   Hong, Fashui ^a   Tang, Meng ^b,c  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c Southeast University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ALKALINE PHOSPHATASE; DNA; LACTATE DEHYDROGENASE; MESSENGER RNA; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TITANIUM DIOXIDE;

ADA GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL PROLIFERATION; CELL STRESS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; DNA DAMAGE; F7 GENE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HISTOPATHOLOGY; HMGCS2 GENE; INFLAMMATORY CELL; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LONG TERM EXPOSURE; LUNG INJURY; LUNG TOXICITY; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOUSE; NANOTOXICOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PNEUMONIA; RAMAN SPECTROMETRY; TBCB GENE;

EID: 84873597595     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0297254     Document Type: Erratum

References (48)

1. Roco MS, Bainbridge WS, editors (2001) Societal implications of nanoscience and nanotechnology. National Science Foundation, NSET Workshop Report Kluwer Academic Publishers: Norwell, MA.
2. Jortner J, Rao CNR, (2002) Nanostructured advanced materials: perspectives and directions. Pure Appl Chem 74: 1491-1506.
3. Thurn KT, Arora H, Paunesku T, Wu A, Brown EM, et al. (2011) Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. Nanomedicine 7: 123-130.
4. Donaldson K, Stone V, Clouter A, Renwick L, MacNee W, (2001) Ultrafine particles. Occup Environ Med 58: 211-216.
5. Hoyt VW, Mason E, (2008) Nanotechnology: emerging health issues. Chem Health Saf 15: 10-15.
6. Pan Z, Lee W, Slutsky L, Clark RAF, Pernodet N, et al. (2009) Adverse affects of titanium dioxide nanoparticles on human dermal fibroblasts and how to protect cells. Small 5: 511-520.
7. Oberdörster G, Oberdörster E, Oberdörster J, (2005) Nanotechnology: an emerging discipline evolving from studied of ultrafine particles. Environ Health Perspect113: 823-839.
8. Liu R, Yin LH, Pu YP, Liang GY, Zhang J, et al. (2009) Pulmonary toxicity induced by three forms of titanium dioxide nanoparticles via intra-tracheal instillation in rats. Prog Nat Sci 19, 573-579.
9. Sun QQ, Tan DL, Ze YG, Liu XR, Zhou QP, et al. (2012) Oxidative damage of lung and its protective mechanism in mice caused by long-term exposure to titanium dioxide nanoparticles. J Biomed Mater Res Part A 100(10): 2554-2562.
10. Sun QQ, Tan DL, Ze YG, Sang XZ, Liu XR, et al. (2012) Pulmotoxicological effects caused by long term titanium dioxide nanoparticules exposure in mice. J Hazard Mater 235-236: 47-53.
11. Katsuma S, Nishi K, Tanigawara K, Ikawa H, Shiojima S, et al. (2001) Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling. Biochem Biophys Res Commun 288: 747-751.
12. McDowell SA, Gammon K, Zingarelli B, Bachurski CJ, Aronow BJ, et al. (2003) Inhibition of nitric oxide restores surfactant gene expression following nickel-induced acute lung injury. Am J Respir Cell Mol Biol 28: 188-198.
13. Kaminski N, Rosas IO, (2006) Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? Proc Am Thorac Soc 3: 339-344.
14. Studer SM, Kaminski N, (2007) Towards systems biology of human pulmonary fibrosis. Proc Am Thorac Soc 4: 85-91.
15. Chen HW, Su SF, Chien CT, Lin WH, Yu SL, et al. (2006) Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J 20: 2393-2395.
16. Chou CC, Hsiao HY, Hong QS, Chen CH, Peng YW, et al. (2008) Single-walled carbon nanotubes can induce pulmonary injury in mouse model. Nano Lett 8: 437-445.
17. Fujita K, Morimoto Y, Ogami A, Myojy T, Tanaka I, et al. (2009) Gene expression profiles in rat lung after inhalation exposure to C60 fullerene particles. Toxicol 258: 47-55.
18. Yang P, Lu C, Hua N, Du Y, (2002) Titanium dioxide nanoparticles co-doped with Fe3+ and Eu3+ ions for photocatalysis. Mater Lett 57: 794-801.
19. Hu RP, Zheng L, Zhang T, Cui YL, Gao GD, et al. (2011) Molecular mechanism of hippocampal apoptosis of mice following exposure to titanium dioxide nanoparticles. J Hazard Mater 191: 32-40.
20. AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S, (2009) Cytotoxicity and Ggenotoxicity of silver nanoparticles in human cells. Acs Nano 3: 279-290.
21. Kacharmina JE, Crino PB, Eberwine J, (1999) Preparation of cDNA from single cells and subcellular regions. Method Enzymol 303: 13-18.
22. Ke LD, Chen Z, (2000) A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards. Mol. Cell Probes 14: 127-135.
23. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
24. Liu WH, Saint DA, (2002) Validation of a quantitative method for real time PCR kinetics. Biochem. Biophys Res Commun 294: 347-353.
25. Grassian VH, Óshaughnessy PT, Adamcakova-Dodd A, Pettibone JM, Thorne PS, (2007) Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environ Health Perspect 115: 397-402.
26. Li J, Li Q, Xu J, Li J, Cai X, et al. (2007) Comparative study on the acute pulmonary toxicity induced by 3 and 20 nm TiO2 primary particles in mice. Environ. Toxicol Pharmacol 24: 239-244.
27. Monteiller C, Tran L, MacNee W, Jones A, Miller B, et al. (2007) The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 64: 609-615.
28. Inoue K, Takano H, Yanagisawa R, Koike E, Shimada A, (2009) Size effects of latex nanomaterials on lung inflammation in mice. Toxicol Appl Pharmacol 234: 68-76.
29. Röhrl J, Yang D, Oppenheim JJ, Hehlgans T, (2010) Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 184: 6688-94.
30. Liljedahl M, Winqvist O, Surh CD, Wong P, Ngo K, et al. (1998) Altered antigen presentation in mice lacking H2-O. Immunity 8: 233-243.
31. Reece JJ, Siracusa MC, Scott AL, (2006) Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages. Infect Immun 74: 4970-4981.
32. Loke P, Gallagher I, Nair MG, Zang XX, Brombacher F, et al. (2007) Alternative activation is an innate response T Cells to be+to injury that requires CD4 sustained during chronic infection. J Immunol 179: 3926-3936.
33. Lee CG, Da Silva CA, Lee JY, Hartl D, Elias JA, (2008) Chitin regulation of immune responses: an old molecule with new roles. Curr Opin Immunol 20: 684-689.
34. Owhashi M, Arita H, Hayai N, (2000) Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein. J Biol Chem 275: 1279-1286.
35. Cai Y, Kumar RK, Zhou J, Foster PS, Webb DC, (2009) Ym1/2 promotes Th2 cytokine expression by inhibiting 12/15(S)-lipoxygenase: identification of a novel pathway for regulating allergic infl{ligature}ammation. J Immunol 182: 5393-5399.
36. Peters-Golden M, Henderson Jr WR, (2007) Leukotrienes. N Engl J Med 357: 1841-1854.
37. Kajimoto K, Shioji K, Ishida C, Iwanaga Y, Kokubo Y, et al. (2005) Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population. Circ J 69: 1029-1034.
38. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402.
39. Mohsenin A, Mi T, Xia Y, Kellems RE, Chen JF, et al. (2007) Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice. Am J Physiol Lung Cell Mol Physiol 293: L753-L761.
40. Hirschorn R, Candotti F (2006) Immunodeficiency due to defects of purine metabolism. In: Ochs H, Smith C, Puck J, eds. Primary immunodeficiency diseases. Oxford, England: Oxford University Press, 169-96.
41. Albuquerque W, Gaspar HB, (2004) Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency. J Pediatr 144: 278-80.
42. Jacobson MA, Bai TR (1997) The role of adenosine in asthma. In Purinergic Approaches in Experimental Therapeutics (Jacobson, K.A. and Jarvis, M.F., eds) 315-331, Wiley-Liss.
43. Fozard JR, Hannon JP, (1999) Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD. Pulm PharmacolTher 12: 111-114.
44. Blackburn MR, (2003) Too much of a good thing: adenosine overload in adenosinedeaminase-deficient mice. TRENDS in Pharmacol Sci 24: 66-70.
45. Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E, (2010) Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res 704: 12-20.
46. Ito Y, Yoshida H, Nakano K, Kobayashi K, Yokozawa T, et al. (2002) Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues. Int J Mol Med 9: 373-376.
47. Whiston EA, Sugi N, Kamradt MC, Sack C, Heimer SR, et al. (2008) αB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect Immun 76: 1781-1790.
48. Koga K, Kenessey A, Powell SR, Sison CP, Miller EJ, et al. (2011) Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid Redox Signal 14: 1191-1202.